The report also profiles emerging innovators bringing AI-powered diagnostics, rapid sepsis panels, and cost-effective molecular tools to market, emphasizing the industry’s ongoing focus on speed, ...

“MERCURIUS™ Total DRUG-seq represents a new frontier in transcriptome-scale compound screening,” said Riccardo Dainese, CEO and Co-founder of Alithea Genomics. “We are empowering scientists to capture ...

In this role, Greg Kraus will lead project and operational excellence initiatives across Allient sites contributing to defense market solutions, while also serving as General Manager of Allient’s ...

PolarSeal®, the flexible medical device partner, today announces the appointment of Chris Locke as Chief Technology Officer (CTO) – a key strategic move that reinforces its commitment to enabling ...

Small- to medium-sized AAAs (3.5–5.0 cm in women, 3.5–5.5 cm in men) are typically managed with imaging surveillance, as no proven therapeutic interventions currently exist for this patient group.

Strong teeth and healthy gums don’t happen by chance. They come from steady care, done every single day. What you do in small moments adds up to a big difference over time. Most problems don’t start ...

Seed, a microbiome science company, today announced the nationwide retail launch of its clinically validated microbiome innovations at Sprouts Farmers Market. Beginning this week, Seed’s DS-01® Daily ...

The first cohort in the ongoing clinical Phase 2a study EXIST evaluated a lower dose of exidavnemab compared to placebo in patients with Parkinson’s disease. An interim safety review showed that ...

NanoHive Medical, LLC, a leading innovative 3D printed spinal implant technology company is pleased to announce that the company has secured the exclusive sublicense of DirectSync Surgical’s ...

Partnership Combines VERAXA’s Proprietary ADC Technology with OmniAb’s Antibody Discovery Technology for Novel Therapies Targeting Solid Tumors.

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical ...

Neurodon Corp., a leader in the development of endoplasmic reticulum (ER) stress-targeted therapeutics for diabetes and neurodegeneration, welcomes Frederick Beddingfield, III, M.D., Ph.D., a 22-year ...